Phenotypes of organ involvement in sarcoidosis

Sarcoidosis is a highly variable, systemic granulomatous disease of hitherto unknown aetiology. The GenPhenReSa (Genotype–Phenotype Relationship in Sarcoidosis) project represents a European multicentre study to investigate the influence of genotype on disease phenotypes in sarcoidosis. The baseline phenotype module of GenPhenReSa comprised 2163 Caucasian patients with sarcoidosis who were phenotyped at 31 study centres according to a standardised protocol. From this module, we found that patients with acute onset were mainly female, young and of Scadding type I or II. Female patients showed a significantly higher frequency of eye and skin involvement, and complained more of fatigue. Based on multidimensional correspondence analysis and subsequent cluster analysis, patients could be clearly stratified into five distinct, yet undescribed, subgroups according to predominant organ involvement: 1) abdominal organ involvement, 2) ocular–cardiac–cutaneous–central nervous system disease involvement, 3) musculoskeletal–cutaneous involvement, 4) pulmonary and intrathoracic lymph node involvement, and 5) extrapulmonary involvement. These five new clinical phenotypes will be useful to recruit homogenous cohorts in future biomedical studies. Five new clinical phenotypes of sarcoidosis have been identified by analysing organ manifestations of 1932 patients http://ow.ly/UYLC30jpUkq

[1]  Y. Cozier Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions , 2016, European Respiratory Journal.

[2]  D. Maucort-Boulch,et al.  Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis , 2016, European Respiratory Journal.

[3]  J. Grunewald,et al.  Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden , 2016, European Respiratory Journal.

[4]  T. Fingerlin,et al.  Genetics of Sarcoidosis. , 2015, Clinics in chest medicine.

[5]  R. Baughman,et al.  Clinical phenotypes in sarcoidosis , 2014, Current opinion in pulmonary medicine.

[6]  A. Prasse,et al.  The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. , 2014, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[7]  E. Horváth-Puhó,et al.  Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study , 2013, The American Journal of Gastroenterology.

[8]  D. Lackland,et al.  The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. , 2012, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[9]  K. Golnik,et al.  Neuro-ophthalmic sarcoidosis. , 2012, Eye and brain.

[10]  P. Rosenstiel,et al.  Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes , 2010, European Respiratory Journal.

[11]  陶仲为 Sarcoidosis , 2009 .

[12]  S. Löfgren Primary Pulmonary Sarcoidosis.1 , 2009 .

[13]  S. Ratcliffe,et al.  GEEQBOX: A MATLAB Toolbox for Generalized Estimating Equations and Quasi-Least Squares , 2008 .

[14]  Sébastien Lê,et al.  FactoMineR: An R Package for Multivariate Analysis , 2008 .

[15]  S. Kudoh,et al.  Epidemiology of sarcoidosis in Japan , 2008, European Respiratory Journal.

[16]  A. Prasse,et al.  Phenotyping sarcoidosis from a pulmonary perspective. , 2008, American journal of respiratory and critical care medicine.

[17]  Christian Hennig,et al.  Cluster-wise assessment of cluster stability , 2007, Comput. Stat. Data Anal..

[18]  R. Elston,et al.  Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study , 2007, Genes and Immunity.

[19]  D. Anantham,et al.  Sarcoidosis in Singapore: Epidemiology, clinical presentation and ethnic differences , 2007, Respirology.

[20]  M. Yigla,et al.  Sarcoidosis in residents of northern Israel of Arabic and Jewish origin: a comparative study , 2006, Respirology.

[21]  R. Elston,et al.  Comparison of sarcoidosis phenotypes among affected African-American siblings. , 2006, Chest.

[22]  Michael Krawczak,et al.  PopGen: Population-Based Recruitment of Patients and Controls for the Analysis of Complex Genotype-Phenotype Relationships , 2006, Public Health Genomics.

[23]  Milton D. Rossman,et al.  COMPLICATIONS OF VIDEO ASSISTED THORACOSCOPIC LUNG BIOPSY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE , 2005 .

[24]  D. Lackland,et al.  Relationship of environmental exposures to the clinical phenotype of sarcoidosis. , 2005, Chest.

[25]  C. Rand,et al.  The diagnostic pathway to sarcoidosis. , 2003, Chest.

[26]  M. Judson Hepatic, Splenic, and Gastrointestinal Involvement with Sarcoidosis , 2002, Seminars in respiratory and critical care medicine.

[27]  G. McLennan,et al.  Clinical characteristics of patients in a case control study of sarcoidosis. , 2001, American journal of respiratory and critical care medicine.

[28]  G. Hillerdal,et al.  Increased risk for cancer following sarcoidosis. , 1999, American journal of respiratory and critical care medicine.

[29]  D. Lackland,et al.  Geographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators. , 1999, American journal of epidemiology.

[30]  R. Baughman,et al.  Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. , 1999, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[31]  R. Loddenkemper,et al.  Clinical findings in 715 patients with newly detected pulmonary sarcoidosis--results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft für die Therapie von Lungenkrankheitan. , 1998, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[32]  M. Yamaguchi,et al.  Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? , 1997, Clinics in chest medicine.

[33]  D. Palli,et al.  A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). , 1996, Scandinavian journal of gastroenterology.

[34]  M. Ohmichi,et al.  The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. , 1996, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[35]  J. Stocks,et al.  Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. , 1995, The European respiratory journal.

[36]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[37]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[38]  L. Elveback,et al.  The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. , 1986, American journal of epidemiology.

[39]  D. James,et al.  Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. , 1983, The Quarterly journal of medicine.

[40]  W. Roberts,et al.  Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II) , 1977 .

[41]  J. Scadding Prognosis of Intrathoracic Sarcoidosis in England , 1961, British medical journal.

[42]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[43]  Julie Josse,et al.  Principal component methods - hierarchical clustering - partitional clustering: why would we need to choose for visualizing data? , 2010 .

[44]  H. Reynolds,et al.  Sarcoidosis: Impact of Other Illnesses on the Presentation and Management of Multi-Organ Disease , 2002, Lung.

[45]  Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. , 1994, The European respiratory journal.